Atavistik Bio

atavistikbio.com

Atavistik Bio is a pre-clinical biotechnology company focused on discovering precision allosteric therapeutics by leveraging the body's natural regulators. Their proprietary Atavistik Metabolite-Proprietary Screening (AMPS) platform integrates advanced computational and experimental techniques to identify novel allosteric binding pockets, enabling rapid drug development for high-value targets in precision oncology and rare diseases. The company aims to transform patient care by addressing serious unmet medical needs through innovative drug discovery, positioning itself as a leader in the precision medicine space.